CMS Raises 2026 Medicare Advantage Reimbursement, Adjusts Drug Coverage Policies
CMS increases 2026 Medicare Advantage reimbursement rates to 5.06%, easing insurer pressures while adjusting policies on obesity drug coverage and billing practices.
Trump Executive Order on Drug Pricing Targets Medicare, 340B Reimbursements
Summary of Trump's executive order directing HHS to reduce prescription drug costs, focusing on Medicare reimbursement for 340B drugs, IRA drug pricing provisions, and CMS premium stabilization efforts.